Jeffrey Robert Ajer Nektar Therapeutics (NKTR) insider trading activity

Jeffrey Robert Ajer is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 34,153 shares of NKTR, which is worth approximately $42,349. The most recent transaction as insider was on Sep 18, 2023, when has been sold 4,359 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $3,007. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.2K

0% 3M change

11.32% 12M change

Total Value Held $42,349

Jeffrey Robert Ajer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2023	SELL Open market or private sale	$3,007 $0.69 p/Share	4,359 Reduced 11.32%	34,153 Common Stock
Sep 23 2022	SELL Open market or private sale	$13,266 $3.16 p/Share	4,198 Reduced 9.83%	38,512 Common Stock
Sep 16 2022	BUY Grant, award, or other acquisition	-	10,200 Added 19.28%	42,710 Common Stock
Sep 22 2021	SELL Open market or private sale	$65,164 $17.78 p/Share	3,665 Reduced 10.13%	32,510 Common Stock
Sep 22 2021	BUY Grant, award, or other acquisition	-	10,200 Added 21.99%	36,175 Common Stock
Sep 28 2020	SELL Open market or private sale	$56,062 $17.25 p/Share	3,250 Reduced 11.12%	25,975 Common Stock

Also insider at

BMRN

BIOMARIN PHARMACEUTICAL INC Healthcare

EVP, Chief Commercial Officer

JRA